Back

Cardiovascular

Atrial Fibrillation

Talk to sales

The clinical case of Mr. Rogers

A 68-year-old male patient attends a cardiology consultation for hypertension. He reports mourning headaches for more than 1 year. He his obese. No other relevant previous medical history.

Learning goals

  • Atrial Fibrillation diagnosis
  • Atrial Fibrillation treatment according to the latest ESC/EACTS guidelines

Phases

  1. Patient assessment
  2. Atrial Fibrillation diagnosis
  3. Treatment plan including comorbidities

Key medication

  • Diuretics
  • Angiotensin receptor blockers (ARBs)
  • Angiotensin-converting enzyme inhibitors (ACEIs)
  • Beta blockers
  • Statins
  • Anticoagulants
  • Digoxin
  • Amiodarone
  • Antiplatelet therapy

References

  • Hindricks G., et al. ESC Scientific Document Group, 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC, European Heart Journal, Volume 42, Issue 5, 1 February 2021, Pages 373–498
  • January, Craig T., et al. «2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation». Journal of the American College of Cardiology, vol. 74, n. 1, Julho de 2019, pp. 104–32. DOI.org (Crossref), https://doi.org/10.1016/j.jacc.2019.01.011.
  • Arbelo, Elena, et al. «Quality Indicators for the Care and Outcomes of Adults with Atrial Fibrillation». EP Europace, vol. 23, n. 4, Abril de 2021, pp. 494–95. DOI.org (Crossref), https://doi.org/10.1093/europace/euaa253.
  • Writing Committee Members, et al. «2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures». Circulation: Cardiovascular Quality and Outcomes, vol. 14, n. 1, Janeiro de 2021. DOI.org (Crossref), https://doi.org/10.1161/HCQ.0000000000000100.

Browse other clinical cases

Cardiovascular

Heart Failure

Cardiovascular

Chronic obstructive pulmonary disease

Cardiovascular

Coxarthrosis

Move towards Patient-Centered care with UpHill

Talk to Sales